Replies to post #40750 on Quantum Materials Corp. (fka QTMM)

[Spartak11]

Good question. I looked at a random 15 just now and we were actually larger than most. Those trading above a dollar were bigger but hardly any under were. That's with my underatanding of QTMM at around 58 mil cap. With the current data available, I personally believe we are still slightly undervalued just on potential alone. Which, I believe is only getting stronger. I think most of us can remember the .05 days with not even star park.

It's safe to say QMC is close, but they have to get a sale. I am personally more optomistic than I have been in the last two years I have been here.

[BigE1960]

I was curious too and have started gathering the info. Here is the data for the first 30 of the 257 (in alphabetic order):


22nd Century Group, Inc. 42.01
Abeona Therapeutics, Inc. 161.54
Accurexa Inc. 9.41
AcelRx Pharmaceuticals, Inc. 196.58
Acme United Corporation 61.06
Actinium Pharmaceuticals, Inc. 91.02
ADMA Biologics, Inc. 103.42
Aemetis, Inc. 65.23
Aeterna Zentaris Inc. 13.84
Aethlon Medical, Inc. 52.13
Agenus Inc. 640.74
Agile Therapeutics, Inc. 196.66
Alliqua BioMedical, Inc. 128.94
Amarin Corporation plc 414.17
American DG Energy Inc. 20.26
AmpliPhi Biosciences Corporation 52.63
Amyris, Inc. 258.32
Aoxing Pharmaceutical Company, Inc. 108.57
Apricus Biosciences, Inc. 58.48
ARCA biopharma, Inc. 56.91
Arch Therapeutics, Inc. 28.68
Arno Therapeutics, Inc. 7.76
Ascent Solar Technologies, Inc. 4.59
Asterias Biotherapeutics, Inc. 152.66
Atossa Genetics Inc. 27.3
Aurinia Pharmaceuticals Inc. 113.25
Avino Silver & Gold Mines Ltd. 39.18
Avita Medical Limited 19.84
Bellerophon Therapeutics LLC 78.46
Bio Blast Pharma Ltd. 81.82

That's 18 on NASDAQ, 8 on NYSE, and 4 on the OTC.